These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6271894)

  • 1. Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation.
    Dutko FJ; Oldstone MB
    J Exp Med; 1981 Nov; 154(5):1636-51. PubMed ID: 6271894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?
    Oldstone MB; Tishon A; Dutko FJ; Kennedy SI; Holland JJ; Lampert PW
    J Virol; 1980 Apr; 34(1):256-65. PubMed ID: 7373708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.
    Brautigam AR; Dutko FJ; Olding LB; Oldstone MB
    J Gen Virol; 1979 Aug; 44(2):349-59. PubMed ID: 230287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the restriction of ecotropic murine retrovirus replication in mouse teratocarcinoma cells.
    D'Auriol L; Yang WK; Tobaly J; Cavalieri F; Peries J; Emanoil-Ravicovitch R
    J Gen Virol; 1981 Jul; 55(Pt 1):117-22. PubMed ID: 6271898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.
    Liu XF; Swaminathan S; Yan S; Engelmann F; Abbott DA; VanOsdol LA; Heald-Sargent T; Qiu L; Chen Q; Iovane A; Zhang Z; Abecassis MM
    J Gen Virol; 2019 Dec; 100(12):1680-1694. PubMed ID: 31647403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance.
    Harnett GB; Shellam GR
    J Gen Virol; 1982 Sep; 62 (Pt 1)():39-47. PubMed ID: 6290595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
    Pollock JL; Virgin HW
    J Virol; 1995 Mar; 69(3):1762-8. PubMed ID: 7853515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine teratocarcinoma stem cell line carries suppressed oncogenic virus genomes.
    Huebner K; Tsuchida N; Green C; Croce CM
    J Exp Med; 1979 Aug; 150(2):392-405. PubMed ID: 458380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of murine p30 by superinfecting herpesviruses.
    Reed CL; Rapp F
    J Virol; 1976 Sep; 19(3):1028-33. PubMed ID: 184296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1.
    Tenney DJ; Morahan PS
    J Immunol; 1987 Nov; 139(9):3076-83. PubMed ID: 2822803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of murine cytomegalovirus in murine and heterologous brain cell cultures. Brief report.
    Barabas G; Wroblewska Z; Gilden DH
    Arch Virol; 1980; 65(2):193-200. PubMed ID: 6252869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection.
    Olding LB; Kingsbury DT; Oldstone MB
    J Gen Virol; 1976 Nov; 33(2):267-80. PubMed ID: 186563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted infectivity of ecotropic type C retroviruses in mouse teratocarcinoma cells: studies on viral DNA intermediates.
    Yang WK; d'Auriol L; Yang DM; Kiggnas JO; Ou C; Périès J; Emanoil-Ravicovitch R
    J Supramol Struct; 1980; 14(2):223-32. PubMed ID: 6262577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-specific changes in mouse cells inoculated with a strain of human cytomegalovirus.
    Gönczöl E; Boldogh I; Váczi L
    Acta Microbiol Acad Sci Hung; 1975; 22(3):275-83. PubMed ID: 168741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection of human teratocarcinoma cells in culture.
    Gönczöl E; Andrews PW; Plotkin SA
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():509-15. PubMed ID: 2982999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.